Corsair Capital Management LP Trimmed Aramark (ARMK) Holding; Corillian (CORI) Has 1.79 Sentiment

March 16, 2018 - By Louis Casey

Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. The company has market cap of $429.87 million. It offers Clonidine Transdermal Delivery System , a treatment for hypertension; Fentanyl TDS, a treatment for the management of chronic pain, including cancer-related pain; and Crest Whitestrips for teeth whitening. It currently has negative earnings. The companyÂ’s products under pipeline comprise Twirla, a combination hormonal contraceptive patch, which has completed Phase III clinical trial to deliver ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system that has completed Phase 1 and Phase II a clinical trial for the treatment of severe osteoporosis; and Donepezil and Memantine transdermal systems, which completed Phase I clinical trial for the treatment of Alzheimer's disease.

Corsair Capital Management Lp decreased Aramark (ARMK) stake by 9.66% reported in 2017Q3 SEC filing. Corsair Capital Management Lp sold 30,627 shares as Aramark (ARMK)’s stock rose 2.38%. The Corsair Capital Management Lp holds 286,396 shares with $11.63M value, down from 317,023 last quarter. Aramark now has $10.11 billion valuation. The stock increased 0.27% or $0.11 during the last trading session, reaching $41.11. About 152,916 shares traded. Aramark (NYSE:ARMK) has risen 13.66% since March 16, 2017 and is uptrending. It has underperformed by 3.04% the S&P500.

Investors sentiment increased to 1.01 in Q3 2017. Its up 0.17, from 0.84 in 2017Q2. It increased, as 32 investors sold ARMK shares while 104 reduced holdings. 29 funds opened positions while 85 raised stakes. 228.50 million shares or 0.02% more from 228.44 million shares in 2017Q2 were reported. Westpac Corp holds 14,268 shares. Highland Capital Management Ltd Partnership, a Texas-based fund reported 10,000 shares. Citigroup Incorporated holds 0% or 85,249 shares. Alyeska Inv Grp Limited Partnership holds 0.13% in Aramark (NYSE:ARMK) or 389,216 shares. Bokf Na stated it has 0.02% of its portfolio in Aramark (NYSE:ARMK). Prudential Finance Incorporated invested 0% in Aramark (NYSE:ARMK). Nicholas Ptnrs Limited Partnership reported 86,596 shares stake. Avalon Ltd Liability Corporation stated it has 34,478 shares or 0.04% of all its holdings. Kings Point Mgmt, New York-based fund reported 2,860 shares. Sumitomo Mitsui Asset Mgmt Limited, a Japan-based fund reported 17,750 shares. 489,756 were reported by Aqr Capital Mgmt Ltd Llc. Baring Asset Management Ltd holds 0.09% or 39,135 shares. Steinberg Asset Mgmt Limited Liability Corp has invested 2.73% in Aramark (NYSE:ARMK). Systematic Financial Mngmt Ltd Partnership holds 0.58% of its portfolio in Aramark (NYSE:ARMK) for 707,168 shares. Utd Ser Automobile Association holds 0% in Aramark (NYSE:ARMK) or 8,148 shares.

Analysts await Aramark (NYSE:ARMK) to report earnings on May, 8. They expect $0.42 earnings per share, up 5.00% or $0.02 from last year’s $0.4 per share. ARMK’s profit will be $103.25M for 24.47 P/E if the $0.42 EPS becomes a reality. After $0.54 actual earnings per share reported by Aramark for the previous quarter, Wall Street now forecasts -22.22% negative EPS growth.

Among 14 analysts covering Aramark Holdings Corporation (NYSE:ARMK), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Aramark Holdings Corporation had 38 analyst reports since August 13, 2015 according to SRatingsIntel. Barclays Capital maintained Aramark (NYSE:ARMK) on Thursday, August 11 with “Overweight” rating. The stock of Aramark (NYSE:ARMK) earned “Buy” rating by RBC Capital Markets on Monday, June 26. RBC Capital Markets maintained it with “Buy” rating and $44.0 target in Tuesday, October 3 report. The rating was downgraded by RBC Capital Markets to “Outperform” on Monday, March 13. As per Thursday, March 2, the company rating was upgraded by Goldman Sachs. The company was initiated on Friday, August 26 by Macquarie Research. The stock of Aramark (NYSE:ARMK) earned “Buy” rating by Nomura on Tuesday, October 17. The stock has “Buy” rating by Robert W. Baird on Monday, October 16. The stock of Aramark (NYSE:ARMK) has “Overweight” rating given on Thursday, August 11 by JP Morgan. The firm has “Equal Weight” rating by Barclays Capital given on Tuesday, January 10.

Corsair Capital Management Lp increased Amtrust Finl Svcs Inc (NASDAQ:AFSI) stake by 83,523 shares to 100,055 valued at $6.63M in 2017Q3. It also upped Om Asset Mgmt Plc (NYSE:OMAM) stake by 41,358 shares and now owns 468,680 shares. Natus Medical Inc Del (NASDAQ:BABY) was raised too.

Analysts await Corium International, Inc. (NASDAQ:CORI) to report earnings on May, 10. They expect $-0.41 EPS, up 2.38% or $0.01 from last year’s $-0.42 per share. After $-0.37 actual EPS reported by Corium International, Inc. for the previous quarter, Wall Street now forecasts 10.81% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: